[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Psoriasis Drugs Market is Segmented by Treatment Type (Biologic Drugs, Small Molecule Systemic Drugs, and Tropical Therapies); by Mechanism of action (TNF Alpha Inhibitors, PDE4 Inhibitors, Interleukin Inhibitors, and Other Mechanisms of Action), by Route of Administration type (Oral, Parenteral, and Topical), Regional Forecasts 2021-2027

September 2021 | 200 pages | ID: G1388AD8C23EEN
Bizwit Research & Consulting LLP

US$ 4,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Psoriasis Drugs Market is valued approximately at USD 13.418 billion in 2020 and is projected to grow with a healthy growth rate of more than 9.89% over the forecast period 2021-2027. Psoriasis is a common, chronic, non-communicable skin disease, with no clear cause and cure. It affects the people of all ages, and in all countries. The changing lifestyles of people are leading to increased alcohol consumption and smoking, an unhealthy diet, and sedentary living, which makes people more prone to this condition. The immune system and genetics also play major roles in its development. The treatment of psoriasis is still based on controlling of symptoms. The key driving factors contributing to growth of psoriasis drugs market are increasing disease burden and demand for psoriasis medication in emerging economies for efficient and long-lasting effects. For instance, On 2019, the world health organization has noted that the psoriasis prevalence is on substantial rise from 2.5% in 2011 to 3.6% in 2017., considering psoriasis a serious global problem. Thus, the increasing prevalence of psoriasis and favorable government initiatives are providing boost to the market. Owing to the above-mentioned factors, the market is expected to register a high growth rate during the forecast period. Despite this, potential side-effects of most existing medication, extensive drug development and approval process and importantly, and huge cost for treatment and diagnosis. are expected restraints that could hamper the growth of the market in the long run.

North America is expected to dominate the psoriasis market during the forecast period with the highest CAGR. In North America, the United States holds the largest market share owing to the high prevalence of psoriasis, the presence of favorable government initiatives and the presence of developed healthcare infrastructure, etc.

Major market player included in this report are

Amgen Inc.
AstraZeneca
Biogen Idec
Novartis AG
Celgene Corporation
Dr. Reddy`s Laboratories
Sun pharmaceutical Industries Limited
Pfizer Inc
Johnson and Johnson
Eli Lilly and Company

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Treatment Type:
Biologic Drugs
Small Molecule Systemic Drugs
Tropical Therapies
By Mechanism of action:
TNF Alpha Inhibitors
PDE4 Inhibitors
Interleukin Inhibitors
Other Mechanisms of Action
By Route of Administration:
Oral
Parenteral
Topical
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019
Base year – 2020
Forecast period – 2021 to 2027.

Target Audience of the Global Maple Water Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2027 (USD Billion)
  1.2.1. Psoriasis Drugs Market, by region, 2019-2027 (USD Billion)
  1.2.2. Psoriasis Drugs Market, by Treatment type, 2019-2027 (USD Billion)
  1.2.3. Psoriasis Drugs Market, by Mechanism of action, 2019-2027 (USD Billion)
  1.2.4. Psoriasis Drugs Market, by Role of administration, 2019-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

CHAPTER 2. GLOBAL PSORIASIS DRUGS MARKET DEFINITION AND SCOPE

2.1. Objective of the Study
2.2. Market Definition & Scope
  2.2.1. Scope of the Study
  2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

CHAPTER 3. GLOBAL PSORIASIS DRUGS MARKET DYNAMICS

3.1. Psoriasis Drugs Market Impact Analysis (2019-2027)
  3.1.1. Market Drivers
    3.1.1.1. Need for efficient and long-lasting drugs
    3.1.1.2. Increase in disease burden and demand for psoriasis medication
  3.1.2. Market Restraint
    3.1.2.1. Potential side-effects of existing medication
    3.1.2.2. Extensive drug development and approval process
  3.1.3. Market Opportunities
    3.1.3.1. Increasing prevalence of psoriasis diseases
    3.1.3.2. Favourable government initiatives

CHAPTER 4. GLOBAL PSORIASIS DRUGS MARKET INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
  4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2027)
4.2. PEST Analysis
  4.2.1. Political
  4.2.2. Economical
  4.2.3. Social
  4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion

CHAPTER 5. GLOBAL PSORIASIS DRUGS MARKET, BY TREATMENT TYPE

5.1. Market Snapshot
5.2. Global Psoriasis Drugs Market by Treatment type, Performance - Potential Analysis
5.3. Global Psoriasis Drugs Market Estimates & Forecasts by Treatment type 2018-2027 (USD Billion)
5.4. Psoriasis Drugs Market, Sub Segment Analysis
  5.4.1. Biologic Drugs
  5.4.2. Small Molecule Systemic Drugs
  5.4.3. Tropical Therapies

CHAPTER 6. GLOBAL PSORIASIS DRUGS MARKET, BY MECHANISM OF ACTION

6.1. Market Snapshot
6.2. Global Psoriasis Drugs Market by Mechanism of action, Performance - Potential Analysis
6.3. Global Psoriasis Drugs Market Estimates & Forecasts by Mechanism of action 2018-2027 (USD Billion)
6.4. Psoriasis Drugs Market, Sub Segment Analysis
  6.4.1. TNF Alpha Inhibitors
  6.4.2. PDE4 Inhibitors
  6.4.3. Interleukin Inhibitors
  6.4.4. Other Mechanisms of Action

CHAPTER 7. GLOBAL PSORIASIS DRUGS MARKET, BY ROLE OF ADMINISTRATION

7.1. Market Snapshot
7.2. Global Psoriasis Drugs Market by Role of administration, Performance - Potential Analysis
7.3. Global Psoriasis Drugs Market Estimates & Forecasts by Role of administration 2018-2027 (USD Billion)
7.4. Psoriasis Drugs Market, Sub Segment Analysis
  7.4.1. Oral
  7.4.2. Parenteral
  7.4.3. Topical

CHAPTER 8. GLOBAL PSORIASIS DRUGS MARKET, REGIONAL ANALYSIS

8.1. Psoriasis Drugs Market, Regional Market Snapshot
8.2. North America Psoriasis Drugs Market
  8.2.1. U.S. Psoriasis Drugs Market
    8.2.1.1. Treatment type breakdown estimates & forecasts, 2018-2027
    8.2.1.2. Mechanism of action breakdown estimates & forecasts, 2018-2027
    8.2.1.3. Route of administration breakdown estimates & forecasts, 2018-2027
  8.2.2. Canada Psoriasis Drugs Market
8.3. Europe Psoriasis Drugs Market Snapshot
  8.3.1. U.K. Psoriasis Drugs Market
  8.3.2. Germany Psoriasis Drugs Market
  8.3.3. France Psoriasis Drugs Market
  8.3.4. Spain Psoriasis Drugs Market
  8.3.5. Italy Psoriasis Drugs Market
  8.3.6. Rest of Europe Psoriasis Drugs Market
8.4. Asia-Pacific Psoriasis Drugs Market Snapshot
  8.4.1. China Psoriasis Drugs Market
  8.4.2. India Psoriasis Drugs Market
  8.4.3. Japan Psoriasis Drugs Market
  8.4.4. Australia Psoriasis Drugs Market
  8.4.5. South Korea Psoriasis Drugs Market
  8.4.6. Rest of Asia Pacific Psoriasis Drugs Market
8.5. Latin America Psoriasis Drugs Market Snapshot
  8.5.1. Brazil Psoriasis Drugs Market
  8.5.2. Mexico Psoriasis Drugs Market
8.6. Rest of The World Psoriasis Drugs Market

CHAPTER 9. COMPETITIVE INTELLIGENCE

9.1. Top Market Strategies
9.2. Company Profiles
  9.2.1. Amgen Inc.
    9.2.1.1. Key Information
    9.2.1.2. Overview
    9.2.1.3. Financial (Subject to Data Availability)
    9.2.1.4. Product Summary
    9.2.1.5. Recent Developments
  9.2.2. AstraZeneca
  9.2.3. Biogen Idec
  9.2.4. Novartis AG
  9.2.5. Celgene Corporation
  9.2.6. Dr. Reddy’s Laboratories
  9.2.7. Sun Pharmaceuticals Industries Limited
  9.2.8. Pfizer Inc
  9.2.9. Johnson & Johnson
  9.2.10. Eli Lilly Company

CHAPTER 10. RESEARCH PROCESS

10.1. Research Process
  10.1.1. Data Mining
  10.1.2. Analysis
  10.1.3. Market Estimation
  10.1.4. Validation
  10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Psoriasis Drugs Market, report scope
TABLE 2. Global Psoriasis Drugs Market estimates & forecasts by region 2018-2027 (USD Billion)
TABLE 3. Global Psoriasis Drugs Market estimates & forecasts by Treatment type 2018-2027 (USD Billion)
TABLE 4. Global Psoriasis Drugs Market estimates & forecasts by Mechanism of action 2018-2027 (USD Billion)
TABLE 5. Global Psoriasis Drugs Market estimates & forecasts by Role of administration 2018-2027 (USD Billion)
TABLE 6. Global Psoriasis Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 7. Global Psoriasis Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 8. Global Psoriasis Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 9. Global Psoriasis Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 10. Global Psoriasis Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 11. Global Psoriasis Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 12. Global Psoriasis Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 13. Global Psoriasis Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 14. Global Psoriasis Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 15. Global Psoriasis Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 16. Global Psoriasis Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 17. Global Psoriasis Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 18. Global Psoriasis Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 19. Global Psoriasis Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 20. Global Psoriasis Drugs Market by segment, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 21. Global Psoriasis Drugs Market by region, estimates & forecasts, 2018-2027 (USD Billion)
TABLE 22. U.S. Psoriasis Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 23. U.S. Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 24. U.S. Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 25. Canada Psoriasis Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 26. Canada Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 27. Canada Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 28. UK Psoriasis Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 29. UK Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 30. UK Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 31. Germany Psoriasis Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 32. Germany Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 33. Germany Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 34. France Psoriasis Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 35. France Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 36. France Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 37. Spain Psoriasis Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 38. Spain Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 39. Spain Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 40. Italy Psoriasis Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 41. Italy Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 42. Italy Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 43. ROE Psoriasis Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 44. ROE Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 45. ROE Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 46. China Psoriasis Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 47. China Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 48. China Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 49. India Psoriasis Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 50. India Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 51. India Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 52. Japan Psoriasis Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 53. Japan Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 54. Japan Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 55. Australia Psoriasis Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 56. Australia Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 57. Australia Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 58. South Korea Psoriasis Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 59. South Korea Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 60. South KoreaPsoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 61. ROPAC Psoriasis Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 62. ROPAC Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 63. ROPAC Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 64. Brazil Psoriasis Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 65. Brazil Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 66. Brazil Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 67. Mexico Psoriasis Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 68. Mexico Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 69. Mexico Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 70. ROLA Psoriasis Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 71. ROLA Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 72. ROLA Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 73. ROW Psoriasis Drugs Market estimates & forecasts, 2018-2027 (USD Billion)
TABLE 74. ROW Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 75. ROW Psoriasis Drugs Market estimates & forecasts by segment 2018-2027 (USD Billion)
TABLE 76. List of secondary sources used in the study of Global Psoriasis Drugs Market.
TABLE 77. List of primary sources used in the study of Global Psoriasis Drugs Market.
TABLE 78. Years considered for the study.
TABLE 79. Exchange rates considered.

LIST OF FIGURES

FIG 1. Global Psoriasis Drugs Market, research methodology
FIG 2. Global Psoriasis Drugs Market, market estimation techniques
FIG 3. Global market size estimates & forecast methods
FIG 4. Global Psoriasis Drugs Market, key trends 2020
FIG 5. Global Psoriasis Drugs Market, growth prospects 2021-2027
FIG 6. Global Psoriasis Drugs Market, porters 5 force model
FIG 7. Global Psoriasis Drugs Market, pest analysis
FIG 8. Global Psoriasis Drugs Market, value chain analysis
FIG 9. Global Psoriasis Drugs Market by segment, 2018 & 2027 (USD Billion)
FIG 10. Global Psoriasis Drugs Market by segment, 2018 & 2027 (USD Billion)
FIG 11. Global Psoriasis Drugs Market by segment, 2018 & 2027 (USD Billion)
FIG 12. Global Psoriasis Drugs Market by segment, 2018 & 2027 (USD Billion)
FIG 13. Global Psoriasis Drugs Market by segment, 2018 & 2027 (USD Billion)
FIG 14. Global Psoriasis Drugs Market by segment, 2018 & 2027 (USD Billion)
FIG 15. Global Psoriasis Drugs Market by segment, 2018 & 2027 (USD Billion)
FIG 16. Global Psoriasis Drugs Market by segment, 2018 & 2027 (USD Billion)
FIG 17. Global Psoriasis Drugs Market, regional snapshot 2018 & 2027
FIG 18. North America Psoriasis Drugs Market 2018 & 2027 (USD Billion)
FIG 19. Europe Psoriasis Drugs Market 2018 & 2027 (USD Billion)
FIG 20. Asia-Pacific Psoriasis Drugs Market 2018 & 2027 (USD Billion)
FIG 21. Latin America Psoriasis Drugs Market 2018 & 2027 (USD Billion)
FIG 22. Global Psoriasis Drugs Market, company market share analysis (2020)


More Publications